Prestige Consumer Healthcare (PBH) Stock Analysis & Winston Score
Prestige Consumer Healthcare sells over-the-counter health and wellness products that people buy without a prescription. Its brands include Clear Eyes eye drops, Monistat, BC Powder, Chloraseptic, and Dramamine, among others. The company focuses entirely on self-care products sold directly to everyday consumers through drugstores, grocery stores, and mass retailers like Walmart and CVS. The company makes money by selling branded consumer health products, relying on brand recognition to charge slightly higher prices than generic alternatives. It operates primarily in the United States, with a smaller international presence, and generates roughly $1.1 billion in annual revenue. Its main competitive advantage is owning a portfolio of trusted, well-known brand names that consumers repeatedly buy out of habit — but the key risk is that private-label store brands continue gaining shelf space and price-conscious shoppers trade down, pressuring both sales volume and margins over time.
Winston Score: 53/100 — Average
Mixed quality — meaningful strengths and weaknesses.
- Quality: Good (15/30)
- Growth: Mixed (5/20)
- Cash Flow: Exceptional (10/10)
- Stability: Strong (8/10)
- Valuation: Strong (8/10)
- Ownership: Mixed (4/15)
Key Facts
Price: $49.92
Market Cap: $2.4B
Sector: Healthcare
Industry: Medical - Distribution


